5-[4-(4-Chlorophenoxy)thieno[2,3-c]pyridin-2-yl]-1,3,4-oxadiazol-2-amine

InChIKey	`LXVBELDBJGYFEM-UHFFFAOYSA-N`
Compound Name	5-[4-(4-Chlorophenoxy)thieno[2,3-c]pyridin-2-yl]-1,3,4-oxadiazol-2-amine
Canonical SMILES	`Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	20
Pfam Stratification	Cross-Family
Avg pChEMBL	6.93
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P49841	GSK3B	Homo sapiens	Human	PF00069	8.5	Ki	ChEMBL
P49840	GSK3A	Homo sapiens	Human	PF00069	8.4	Ki	ChEMBL
P51817	PRKX	Homo sapiens	Human	PF00069	7.7	Ki	ChEMBL
Q9HAZ1	CLK4	Homo sapiens	Human	PF00069	7.5	Ki	ChEMBL
P78368	CSNK1G2	Homo sapiens	Human	PF12605 PF00069	7.4	Ki	ChEMBL
Q13627	DYRK1A	Homo sapiens	Human	PF00069	7.2	Ki	ChEMBL
Q8NE63	HIPK4	Homo sapiens	Human	PF00069	7.2	Ki	ChEMBL
Q9HCP0	CSNK1G1	Homo sapiens	Human	PF12605 PF00069	7.2	Ki	ChEMBL
Q9Y6M4	CSNK1G3	Homo sapiens	Human	PF12605 PF00069	7.0	Ki	ChEMBL
O43781	DYRK3	Homo sapiens	Human	PF00069	6.6	Ki	ChEMBL
O95819	MAP4K4	Homo sapiens	Human	PF00780 PF00069	6.6	Ki	ChEMBL
P06493	CDK1	Homo sapiens	Human	PF00069	6.6	Ki	ChEMBL
Q9H2X6	HIPK2	Homo sapiens	Human	PF00069	6.6	Ki	ChEMBL
P07949	RET	Homo sapiens	Human	PF00028 PF07714 PF17756 PF17812 PF17813 PF22540	6.5	Ki	ChEMBL
P51957	NEK4	Homo sapiens	Human	PF00069	6.5	IC50	ChEMBL
Q12851	MAP4K2	Homo sapiens	Human	PF00780 PF00069	6.4	Ki	ChEMBL
P49760	CLK2	Homo sapiens	Human	PF00069	6.3	Ki	ChEMBL
P24941	CDK2	Homo sapiens	Human	PF00069	6.2	Ki	ChEMBL
P11309	PIM1	Homo sapiens	Human	PF00069	6.1	Ki	ChEMBL
Q9NYL2	MAP3K20	Homo sapiens	Human	PF07714 PF07647	6.1	Ki	ChEMBL